SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
|
Email
Search
Test your basic knowledge |
First Aid Basics
Start Test
Study First
Subjects
:
health-sciences
,
first-aid
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. Squamous cell carcinoma of skin
Neoplasm associated with actinic keratosis
Free radical cell damage
fat benign tumor
S-100
2. Tumor marker: ovarian - malignant epithelial tumors.
CA-125
fat malignant tumor
Necrosis
WT1 gene
3. Enzymes: catalase - superoxide dismutase - glutathione peroxidase.Vitamins: ACE Spontaneous decay
dysplastic nevus
Free radical eliminators
Irreversible - plasias
granulomatous disease
4. Colon cancer (Deleted in Colon Cancer) 18q tumor suppressor
Leukocyte extravasation: tight binding
Alkylating agents target
Neoplasm associated with Down Syndrome
DCC gene
5. Colorectal cancer (assoc with FAP) 5q tumor suppressor
Neoplasm associated with xeroderma pigmentosum (albinism)
Second - leading cause of death in the US
Irreversible - plasias
APC gene
6. PECAM-1
Leukocyte extravasation: diapedesis
Free radical eliminators
Rb gene
secondary amyloidosis (reactive systemic)
7. All - AML
aflatoxin target
blood vessels malignant tumor
Neoplasm associated with Down Syndrome
Napthalene (aniline) dyes target
8. Bacterial products (CLIK):C5a - LTB4 - IL-8 - Kallikrein
NF1 gene
smooth muscle malignant tumor
Leukocyte extravasation: migration
Leukocyte extravasation: diapedesis
9. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.
PSA
Alk - phos
Red (hemorrhagic) infarcts
BRCA1 gene
10. Osteoma
blood cell malignant tumors
Alkylating agents target
bone benign tumor
Colon and rectal cancer incidence
11. 32%/13% male
prostate cancer incidence/mortality
paraneoplastic effects of leukemias and lymphomas
granulomatous disease
Neoplasm associated with actinic keratosis
12. Hepatocellular carcinoma
benign >1 cell type tumor
skeletal muscle benign tumor
cirrosis (alcohol - hepB or C)
Chronic inflammatory mediators
13. Tumor marker: neuroblastoma - lung and gastric cancer
Bombesin
malignant epithelial tumor
PSA
malignant >1 cell type tumor
14. Melanoma - basal cell carcinoma - and especially squamous cell carcinomas of the skin.
Pale infarcts
Prostatic acid phosphatase
Neoplasm associated with xeroderma pigmentosum (albinism)
Second - leading cause of death in the US
15. Lung - liver - intestine or following reperfusion.
secondary amyloidosis (reactive systemic)
Red (hemorrhagic) infarcts
CCl4 target
blood cell malignant tumors
16. Infections - inflammation - cancer - pregnancy - SLE
p16 gene
L- myc gene
ras gene
causes of increased ESR
17. Leiomyosarcoma
DPC gene
AIDS
smooth muscle malignant tumor
prostate cancer incidence/mortality
18. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
Primary tumors that met to brain
skeletal muscle malignant tumor
Where you see Psammoma bodies
DPC gene
19. Follicular and undifferentiated lymphomas anti - apoptotic molecule (oncogene)
malignant >1 cell type tumor
AIDS
bcl -2 gene
skeletal muscle benign tumor
20. Cancer
fat malignant tumor
Where you see Psammoma bodies
p53 gene
Second - leading cause of death in the US
21. Sarcoma
Acute inflammatory mediators
malignant mesenchyme tumor (general)
beta - hCG
WT1 gene
22. Restoration of normal structure - granulation tissue (vascularized + fibrosis) - abscess (fibrosis + pus) - fistula or scarring (collagen).
c - kit gene
prostate cancer incidence/mortality
Resolution of inflammation
TRAP
23. ACTH or ACTH- like peptide
Alkylating agents target
paraneoplastic effects of small cell lung carcinoma
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
NF2 gene
24. Hyperplasia - metaplasia - dysplasia
cirrosis (alcohol - hepB or C)
L- myc gene
abl gene
Reversible - plasias
25. PTH- related peptide - TGF- beta - TNF - IL-1
c - myc gene
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
Autoimmune (Hashimoto's - myasthenia gravis)
erb - B2 gene
26. Astrocytoma - angiomyolipoma - cardiac rhabdomyoma
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
AIDS
DPC gene
N- myc gene
27. Anaplasia - neoplasia - desmoplasia (fibrous tissue formation in response to neoplasm)
bcl -2 gene
causes of decreased ESR
Irreversible - plasias
Napthalene (aniline) dyes target
28. Breast and ovarian cancer 17q tumor suppressor (DNA repair protein)
aflatoxin target
BRCA1 gene
intrinsic apoptosis
blood vessels benign tumor
29. Sickle cell (altered shape) - polycythemia (too many) - CHF (unknown)
S-100
iron poisoning
causes of decreased ESR
Red (hemorrhagic) infarcts
30. AA
p53 gene
Where you see Psammoma bodies
malignant >1 cell type tumor
secondary amyloidosis (reactive systemic)
31. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.
Alkylating agents target
fat malignant tumor
cirrosis (alcohol - hepB or C)
beta - hCG
32. Membrane lipid peroxidation - protein modification and DNA breakage.
Napthalene (aniline) dyes target
Resolution of inflammation
Free radical cell damage
iron poisoning
33. Tumor marker: carcinoembryonic Ag Very nonspecific
cirrosis (alcohol - hepB or C)
arsenic target
p16 gene
CEA
34. Tumor marker: melanoma - neural tumors - astrocytomas
WT1 gene
Leukocyte extravasation: rolling
S-100
cigarette smoke target
35. GIST cytokine receptor (oncogene)
Alk - phos
Free radical eliminators
N- myc gene
c - kit gene
36. Neurofibromatosis type 2 22q tumor suppressor (key type 2=22)
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
breast cancer incidence/mortality
NF2 gene
Napthalene (aniline) dyes target
37. Squamous cell carcinoma of the esophagus
ras gene
breast cancer incidence/mortality
alpha - fetoprotein
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
38. Gastric adenocacinoma
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
CEA
Rb gene
39. Tumor marker: prostate carcinoma marker.
BRCA1 gene
TRAP
Prostatic acid phosphatase
Leukocyte extravasation: tight binding
40. MEN type II and III tyrosine kinase (oncogene)
DCC gene
ret gene
Red (hemorrhagic) infarcts
Necrosis
41. Neutrophils (eos in the gut) - plus other granular leukocytes and antibodies.
Where you see Psammoma bodies
Acute inflammatory mediators
Leukocyte extravasation: tight binding
BRCA1 gene
42. Burkitt's lymphoma transcription factor (oncogene)
c - myc gene
ras gene
iron poisoning
Primary tumors that met to liver
43. AL
immunodeficiency states
primary amyloidosis
p53 gene
Napthalene (aniline) dyes target
44. Solid tissues with single blood supply. Heart - kidney and spleen.
paraneoplastic effects of leukemias and lymphomas
lung cancer incidence/mortality
dysplastic nevus
Pale infarcts
45. Lymphoma
Warning
: Invalid argument supplied for foreach() in
/var/www/html/basicversity.com/show_quiz.php
on line
183
46. ADH
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
bone benign tumor
arsenic target
N- myc gene
47. Visceral malignancy (stomach - lung - breast - uterus)
fat benign tumor
Free radical eliminators
bone malignant tumor
acanthosis nigricans (hyperpig and epidermal thickening)
48. Neurofibromatosis type 1 17q tumor suppressor
bone benign tumor
vinyl chloride target
NF1 gene
skeletal muscle malignant tumor
49. Pancreatic cancer (Deleted in Pancreatic Cancer) 18q tumor suppressor
DPC gene
Neoplasm associated with Down Syndrome
Paget's bone disease
skeletal muscle malignant tumor
50. Tumor marker: tartrate - resistant acid phosphatase. Hairy cell leukemia (B- cell neoplasm)
Rb gene
CA-125
Neoplasm associated with Down Syndrome
TRAP